Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
A societal shift has gradually taken psychedelics out of the basement into the sterile white environment of clinical trials. Robust evidence now suggests use of this type of drugs could treat severe depression, addiction to nicotine or cocaine, and post-traumatic stress disorder (PTSD). With the launch of two dedicated research centers in the past year alone, proponents now say a psychedelic therapeutic agent is within reach in the next five years.